Mycophenolic acid as a latent agonist of PPARγ

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 17, 2007, Pages 4767-4770

  Ubukata, Makoto ^a   Takamori, Hitomi ^a   Ohashi, Misaki ^a   Mitsuhashi, Shinya ^a   Yamashita, Kaoru ^b   Asada, Tomohisa ^b   Nakajima, Noriyuki ^b   Matsuura, Nobuyasu ^c   Tsuruga, Mie ^d   Taki, Keiko ^d   Magae, Junji ^d  

^a HOKKAIDO UNIVERSITY   (Japan)

^b TOYAMA PREFECTURAL UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

^d INSTITUTE OF RESEARCH AND INNOVATION   (Japan)

Author keywords

3T3 L1; IMPDH; Inhibitor; Mycophenolic acid; PPAR ; SPR

Indexed keywords

INOSINATE DEHYDROGENASE; MYCOPHENOLIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; DRUG ACTIVITY; DRUG MECHANISM; FIBROBLAST; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

3T3-L1 CELLS; ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; HUMANS; LIGANDS; MICE; MODELS, CHEMICAL; MYCOPHENOLIC ACID; PPAR GAMMA; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS;

EID: 34547589276     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.06.059     Document Type: Article

References (18)

1. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. JAMA 295 (2006) 1549
2. Reusch J.E.B., Colton L.A., and Klemm D.J. Mol. Cell. Biol. 20 (2000) 1008
3. Mackall J.C., Student A.K., Polakis S.E., and Lane M.D. J. Biol. Chem. 251 (1976) 6462
4. Nishio E., Tomiyama K., Nakata H., and Watanabe Y. Eur. J. Pharmacol. 301 (1996) 203
5. Zhang B., MacNaul K., Szalkowski D., Li Z., Berger J., and Moller D.E. J. Clin. Endocrinol. Metab. 84 (1999) 4274
6. Takahata T., Kumano T., Ookawa K., Hayakari M., Kakizaki I., and Tsuchida S. Biochem. Pharmacol. 67 (2004) 1667
7. Miller C.W., Casimir D.A., and Ntambi J.M. Endocrinology 137 (1996) 5641
8. Uehara T., Tokumitsu Y., and Nomura Y. Biochem. Biophys. Res. Commun. 210 (1995) 574
9. Matsuura N., Yamada M., Suzuki H., Hasegawa N., Kurosaka C., Ubukata M., Tanaka T., and Iinuma M. Biosci. Biotechnol. Biochem. 69 (2005) 2470
10. Cole R.J., and Cox R.H. Handbook of Toxic Fungal Metabolites (1981), Academic Press pp 866-869 mycophenolic acid; pp 769-772 terrein
11. Jones D.F., and Mills S.D. J. Med. Chem. 14 (1971) 305
12. Sokoloski J.A., Blair O.C., and Sartorelli A.C. Cancer Res. 46 (1986) 2314
13. Precise assay conditions will be reported elsewhere. Briefly, 3T3-L1 cells (purchased from Health Science Research Resources Bank (Osaka, Japan)) were cultured in the culture plate doubly coated with poly-l-lysine and collagen, and measurement of triglyceride and genomic DNA in the cell lysate was conducted using a triglyceride E-test kit (Wako) and a PicoGreen dsDNA quantitation Reagent and Kits (Molecular Probes), respectively.
14. Leyssen P., Balzarini J., De Clercq E., and Neyts J. J. Virol. 79 (2005) 1943
15. Uehara Y., Hasegawa M., Hori M., and Umezawa H. Cancer Res. 45 (1985) 5230
16. Togashi M., Ozawa S., Abe S., Nishimura T., Tsuruga M., Ando K., Tamura G., Kuwahara S., Ubukata M., and Magae J. J. Med. Chem. 46 (2003) 4113
17. Kretschmann E., and Raether H. Naturforcshung Teil A 23 (1968) 2135
18. 2 = 0.392 in PBS-P buffer.